Zacks Investment Research on MSN
Is TEM stock a buy, hold, or sell during its pivotal transition?
Tempus AI TEM is transitioning from a heavy-investment growth stage toward improved operating leverage and a more scalable ...
Relation's draw is its 'lab-in-a-loop' process of AI-driven target and drug discovery, in which algorithms are used to find ...
Zacks Investment Research on MSN
Tempus AI: Data flywheel and MRD expansion reshape the outlook
Tempus AI TEM is leaning into a dual-engine model: a fast-growing Genomics franchise and a scaling data business powered by ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that ten abstracts have been accepted for presentation at the 2025 San ...
In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback